EXCLUSIVE ONLINE CONTENT
Nemera recently announced it has entered into an agreement to acquire Copernicus, which specializes in the development and manufacturing of injection devices…
Lonza recently announced a $93-million investment in its Capsules and Health Ingredients (CHI) Division, a dosage form delivery partner to the biopharma and health nutrition industry…..
Catalent and BrainStorm Cell Therapeutics Inc. recently announced an agreement for the manufacture of NurOwn, BrainStorm’s autologous cellular therapy being investigated for the treatment of….
WEBINAR ALERT: Stability Testing as Quality Control Measure: Optimizing the Process Throughout the Product Lifecycle
Assessing a compound’s stability is a complex and lengthy process with objectives varying by the development phase…..
MilliporeSigma has recently bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress Lentiviral Production Platform…..